Heart 1999;81:25-32 ( January )
Blocker treatment and other prognostic variables in patients
with clinical evidence of heart failure after acute myocardial
infarction: evidence from the AIRE study
a Institute for
Cardiovascular Research, University of Leeds, Leeds LS2 9JT, UK, b Subunit for Medical Statistics, University of
Leeds
Correspondence to: Dr Hall.
Accepted for publication 29 July 1998
Objectives
To
examine clinical outcomes associated with optional
blockade in a
population of patients with evidence of heart failure after myocardial infarction.
Design and
patients
Data from the acute infarction ramipril
efficacy (AIRE) study were analysed retrospectively. At baseline 22.3%
of the patients were receiving a
blocker. To minimise confounding,
blocker and diuretic treatments, presence of clinical signs of
heart failure, left ventricular ejection fraction, and 16 other
baseline clinical variables were simultaneously entered in a
multivariate Cox regression model. In addition, the same analysis was
repeated separately within a high and a low risk group of patients, as
defined according to the need for diuretic treatment.
Results
Blocker
treatment was an independent predictor of reduced risk of total
mortality (hazard ratio 0.66, 95% confidence interval (CI) 0.48 to
0.90) and progression to severe heart failure (0.58, 95% CI 0.40 to
0.83) for the entire study population. There were similar findings in
high risk patients requiring diuretics (0.59, 95% CI 0.40 to 0.86; and
0.58, 95% CI 0.38 to 0.89).
Conclusions
Blocker treatment is associated with improved outcomes in patients with
clinical evidence of mild to moderate heart failure after myocardial
infarction. Most importantly, high risk patients with persistent heart
failure appear to benefit at least as much as lower risk patients with
transient heart failure.
blockers
© 1999 by Heart
This article has been cited by other articles:
-
Radford, M. J.
(2006). Percutaneous Coronary Intervention "Dominates" Coronary Artery Bypass Graft Surgery for High-Risk Patients: Good News for Patients, a Challenge for Healthcare Planners. Circulation
114: 1229-1231
[Full Text] -
Gheorghiade, M., Goldstein, S.
(2002). {beta}-Blockers in the Post-Myocardial Infarction Patient. Circulation
106: 394-398
[Full Text] -
Tjeerdsma, G., Szabo, B. M., van Wijk, L. M., Brouwer, J., Tio, R. A., Crijns, H. J.G.M., van Veldhuisen, D. J.
(2001). Autonomic dysfunction in patients with mild heart failure and coronary artery disease and the effects of add-on {beta}-blockade. Eur J Heart Fail
3: 33-39
[Abstract] [Full Text]
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
